Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7938008 | 0.84 | APLNR (0.35) | ALDH1A1TP53ALOX15MAPK1SMN1; SMN2 | |
| SCHEMBL9272403 | 0.84 | APLNR (0.35) | ALDH1A1TP53ALOX15MAPK1SMN1; SMN2 | |
| SCHEMBL6142177 | 0.78 | ALDH1A1 (0.30) | ALDH1A1TP53ALOX15MAPK1SMN1; SMN2 | |
| SCHEMBL29854028 | 0.78 | ALDH1A1 (0.30) | ALDH1A1TP53ALOX15MAPK1SMN1; SMN2 | |
| SCHEMBL12500631 | 0.71 | KMT2A (0.30) | — | |
| SCHEMBL636829 | 0.71 | — | — | |
| SCHEMBL8598869 | 0.67 | GAA (0.31) | — | |
| SCHEMBL11260869 | 0.67 | APLNR (0.41) | ALDH1A1TP53ALOX15MAPK1SMN1; SMN2 | |
| SCHEMBL5246594 | 0.67 | APLNR (0.41) | ALDH1A1TP53ALOX15MAPK1SMN1; SMN2 | |
| SCHEMBL3385056 | 0.67 | APLNR (0.41) | ALDH1A1TP53ALOX15MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0822835-A1 | HYBRID MAGNETIC RESONANCE CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-02-11 | — | — | EP | claimed |
| WO-1996032967-A1 | HYBRID MAGNETIC RESONANCE CONTRAST AGENTS | IMARX PHARMACEUTICAL CORPORATION (US) | 1996-10-24 | — | — | WO | claimed |
| US-5407657-A | Containing a metal chelate and a free radical nitroxide | IMARX THERAPEUTICS, INC. | 1995-04-18 | — | — | US | claimed |
| EP-0822835-A1 | HYBRID MAGNETIC RESONANCE CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-02-11 | — | — | EP | disclosed |
| WO-1996032967-A1 | HYBRID MAGNETIC RESONANCE CONTRAST AGENTS | IMARX PHARMACEUTICAL CORPORATION (US) | 1996-10-24 | — | — | WO | disclosed |
| US-5407657-A | Containing a metal chelate and a free radical nitroxide | IMARX THERAPEUTICS, INC. | 1995-04-18 | — | — | US | disclosed |